English
GenoScreen corporate home
Press
Press contact
Communication Service
Phone: +33(0) 362 263 772
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Our press releases
GenoScreen and Clear Labs Announce the Launch of Clear Dx™ Deeplex® Myc-TB, an Automated Genomic Solution for Mycobacterium Characterization and TB Drug Resistance Detection
GenoScreen and Illumina Partner to Expand Access to Genomic Testing for Multidrug-Resistant Tuberculosis
Deeplex® Myc-TB: Pursue the global deployment of the innovative solution for predicting antibiotic resistance in tuberculosis
Deeplex® Myc-TB, a breakthrough innovation to effectively fight tuberculosis
A microbial signature in indoor air associated with severe asthma
Number of new cases in contacts of leprosy patients decreases after dose of antibiotic
Publication of the first comprehensive performance evaluation of the "Deeplex® Myc-TB" test for the prediction of tuberculosis antibiotic resistance
Tuberculosis: discovery of an ancestral lineage in the African Great Lakes region
GenoScreen launches a rapid, effective diagnostic kit, to combat tuberculosis antibiotic resistance
(French) Grippe : lutter contre les surinfections bactériennes grâce au microbiote
A major advance in the fight against multidrug-resistant tuberculosis
GenoScreen in the news
01/12/2024
OpenPR - Microbial Feed Additives Market Revolutionizing Animal Nutrition for Sustainable Growth
01/10/2024
Te Niwha - Improving the safety and effectiveness of leprosy treatment in Kiribati through enhanced surveillance of drug resistance and detection of factors predisposing to dapsone reactions
01/07/2024
The Standard - Tech key to combating drug-resistant TB in Africa, experts advise
30/05/2024
Adezmapimod Inhibitor - Effects of curve for the dissemination involving undulatory surf within lower sizing stretchy components
04/12/2023
GlobeNewswire - Global Biotechnology Instruments Market Size To Exceed USD 152.5 Billion by 2032 | CAGR of 8.1%
11/2023
WHO - Global Tuberculosis Report
09/2023
Institut Pasteur - 2022 Annual Report
08/2023
Market.us - Pharmacogenomics Market
07/2023
Medical Device Network - Illumina and Pillar collaborate to commercialise oncology assays
03/2023
Medtech Alert - Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa
05/01/2023
360dx - COVID-19 Still a Focus for Infectious Disease Test Developers in 2022, but Ceded Some Ground
About - Beyond genomic analysis
Since its foundation, GenoScreen has developed an ambitious R&D program. This is constantly used to improve the performance level and precision of its genomics and microbiological analysis tools. Our R&D staff has been part of many different international research programs in the healthcare, environmental and hygiene sectors.
Innovation portfolio
Our R&D programs have generated breakthrough technologies in the field of genomics and microbiology:
- Tests for bacterial pathogens,
- Analyses of complex microbiological ecosystems,
- Human genomics and personalized medicine.
Collaborative research
GenoScreen participates in several international research programs with a particular focus on Alzheimer’s disease, the epidemiological surveillance of pathogens and biodiversity.
Publications
Discover the publications made with GenoScreen researchers.
Business areas - Genomic and bioinformatic expertise
GenoScreen, a pioneering company in genomics and bioinformatics, has developed over the years, a portfolio of activities dedicated to the exploration and exploitation of the DNA molecule.
Multi-specialist provider serving academic and industrial R&D
GenoScreen offers a complete catalog of analytical services in genomics and bioinformatics: sequencing and transcriptome analysis of genomes of all types of organisms and microbial metagenomes.
Our strengths:
- The professionalism of a team of experienced genomics and bioinformatics experts,
- Use of sequencing platforms, high and medium throughput,
- The possession of a computer park that ensures the performance of analyzes and the security of data processed and archived,
- Advanced expertise in molecular microbiology,
- Characterization and analysis of microorganisms (all types of strains and microbiota).
Laboratory of high precision analyzes and tests in genomics and microbial metagenomics
GenoScreen carries out genomic tests, inspections and tests with its analysis laboratory operating. The expertise of its teams and the prevalence of collaborative mode bring confidence and security to a diversified clientele (all sizes, all sectors of activity).
Since 2016, our laboratory has been mobilized mainly for analyzes related to the identification and characterization of microorganisms and microbiota acting within organs, organisms or environment.
Discover our advanced genomic analysis solutions
A trusted partner to facilitate and accelerate R&D projects
GenoScreen mobilizes its technological resources and its R&D teams to meet the needs of academic and industrial researchers seeking expertise in genomics, metagenomics and bioinformatics.
Our interventions can be carried out as a partner or provider (services eligible for the Research Tax Credit in France). These activities are carried out under the guise of agreements that make it possible to specify the objectives pursued, the methods of carrying out the work and the desired guarantees regarding confidentiality.
Supplier of solutions and tools dedicated to the detection and analysis of microorganisms
GenoScreen develops optimized solutions for detecting, identifying, characterizing and tracing microorganisms and for analyzing microbiotics of interest for diagnostic or therapeutic projects. The solutions developed concern healthcare, nutrition or environmental professionals.
Two product lines, consisting of a genomic compartment and a software suite, are undergoing continuous development:
- The Metabiote® product line for the molecular microbiota study
- The Deeplex® product line for molecular analysis of mycobacteria
GenoScreen also offers advanced training in relation to its expertise (genomics, metagenomics...).
History
GenoScreen develops advanced DNA analysis services and technologies for research and innovation in the life sciences. Thanks to constant investment in R&D and specialization in molecular microbiology, our evolution has been built in three stages:
A look back at the key moments in our history
About GenoScreen
GenoScreen has been a pioneer in genomics and bioinformatics since 2001. Specializing in sequencing, genotyping and the development of analytical solutions, GenoScreen offers innovative genomics services tailored to the needs of academic and industrial research teams. Based in France, on the Institut Pasteur campus in Lille, GenoScreen is at the forefront of genomic technologies, developing R&D programs that fuel its technological advance. This dynamic of continuous innovation enables the creation of high value-added products and services, recognized for their quality, precision and reliability.
GenoScreen provides 3 types of solutions
GenoScreen in figures
Our genomics expertise
With more than 20 years' experience, GenoScreen offers a wide range of services in genomics, metagenomics and bioinformatics, supported by a high-performance, fully-equipped technology platform. Our expertise covers all steps, from genomic data processing and sequencing to bioinformatics analysis, to provide reliable results for researchers in human health, animal health, plant sciences and environmental sciences.
As a leader in various genomics technologies, GenoScreen has rapidly expanded internationally, bringing its solutions to a wide range of research teams. In 2024, GenoScreen's expert services and solutions are appreciated in over 20 countries.
Innovative genomics and molecular microbiology services
GenoScreen puts genomics at the service of your scientific and industrial challenges, with solutions and recognized expertise in :
- Microbial genomics: microbiota, pathogens, industrial strains
- Biodiversity analysis: species monitoring, conservation, ecosystem health
- Applied genomics: sequencing, bioinformatics, interpretation
Our strengths
- Customized support, from experimental design to interpretation of results
- Close customer relations with a dedicated contact
- Clear, usable results, whatever the level of expertise
We operate in 5 major sectors
Research, innovation and scientific commitment
Our commitment to research and development is reflected in our continuous development of innovative genomics technologies. Our services support researchers in their projects, from genomic analysis to data interpretation, with a high level of personalization and scientific support.
Our values
Our management board
New EFSA Guidance for microorganisms (2025) : What changes and how GenoScreen help you stay fully compliant
Following its agenda to regulate the Food and Feed industry with up-to-date regulatory texts, the EFSA significantly raised the technical expectations for the characterisation and risk assessment of microorganisms used in food and feed. As of November 4th, 2025, dossiers that rely on outdated genomic analysis, incomplete resistance screening or legacy databases may no longer meet regulatory expectations.
Subcategories
GenoScreen
Collaborative research - At the heart of international innovation in genomics
GenoScreen is a partner in collaborative research projects that bring together startups, multinationals and public-sector organizations. Our R&D teams provide their knowledge and expertise in the molecular microbiology of isolated agents and complex communities. This allowed our teams to develop our own projects for elaborating innovative products and services.
Our projects are designed to:
- Improve the diagnosis and management of acute/chronic diseases on humans and animals,
- Characterize and monitor microbial biodiversity, with applications in agronomy, agrifood and environment.
The common feature of these projects is the development of molecular tools for the characterization, monitoring and diagnosis of microbial communities. The key objective is to market simple analytical solutions and (ultimately) preventive, corrective or even therapeutic products based on microorganisms.